Akebia Therapeutics is based in Cambridge. It has raised $115M in total funding. Latest round: IPO. Backed by BlackRock, DRX Capital, Venture Investors.
Akebia Therapeutics funding overview
Akebia Therapeutics is based in Cambridge. Akebia Therapeutics has raised $115M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in March 2014. The round record for Akebia Therapeutics runs through 2014; nothing later has been disclosed. Investors on record include BlackRock, DRX Capital, Venture Investors, Novartis, Athenian Venture Partners, Kearny Venture Partners and 9 others. 15 distinct backers are named across the disclosed rounds.
Frequently asked about Akebia Therapeutics funding
How much has Akebia Therapeutics raised?
Akebia Therapeutics has raised $115M in total disclosed funding across the rounds on record.
Who has invested in Akebia Therapeutics?
BlackRock, DRX Capital, Venture Investors, Novartis, Athenian Venture Partners, Kearny Venture Partners are named among the investors backing Akebia Therapeutics.
What was the latest Akebia Therapeutics funding round?
The most recent disclosed round is an IPO, announced in March 2014.
Where is Akebia Therapeutics based?
Akebia Therapeutics is based in Cambridge.
When did Akebia Therapeutics last raise?
The last disclosed Akebia Therapeutics round closed in March 2014 at IPO.
We update the Akebia Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Cambridge and their backers are listed below.
